Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  DELIVERABLE VOLUME
Deliverable Volume      
Aarti Pharmalabs Ltd.
BSE Code 543748
ISIN Demat INE0LRU01027
Book Value 188.35
NSE Code AARTIPHARM
Dividend Yield % 0.53
Market Cap 51711.20
P/E 25.08
EPS 22.75
Face Value 5  
Exchange : Period From : Period To :
DateTotal VolumeDeliverable VolumeDeliverable Volume [%]
20-Dec-2024 18425 6759 36.68
19-Dec-2024 552649 532908 96.43
18-Dec-2024 29543 23180 78.46
17-Dec-2024 16538 9944 60.13
16-Dec-2024 7439 3550 47.72
13-Dec-2024 19665 7762 39.47
12-Dec-2024 19627 8299 42.28
11-Dec-2024 12876 6298 48.91
10-Dec-2024 6372 4550 71.41
09-Dec-2024 15134 8194 54.14
06-Dec-2024 4585 2846 62.07
05-Dec-2024 6791 3255 47.93
04-Dec-2024 5637 2659 47.17
03-Dec-2024 9689 5440 56.15
02-Dec-2024 16514 9927 60.11
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.